# Netarsudil Use After Descemetorhexis Without Endothelial Keratoplasty

> **NCT04057053** · EARLY_PHASE1 · COMPLETED · sponsor: **Massachusetts Eye and Ear Infirmary** · enrollment: 10 (actual)

## Conditions studied

- Fuchs' Endothelial Dystrophy
- Cataract

## Interventions

- **DRUG:** Netarsudil 0.02% Ophthalmic Solution

## Key facts

- **NCT ID:** NCT04057053
- **Lead sponsor:** Massachusetts Eye and Ear Infirmary
- **Sponsor class:** OTHER
- **Phase:** EARLY_PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2018-10-02
- **Primary completion:** 2020-12-20
- **Final completion:** 2020-12-20
- **Target enrollment:** 10 (ACTUAL)
- **Last updated:** 2021-01-26


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04057053

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04057053, "Netarsudil Use After Descemetorhexis Without Endothelial Keratoplasty". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT04057053. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*